These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34271825)

  • 1. Risk of Invasive Fungal Infections and Osteonecrosis of Jaw in Patients Exposed to Current Therapeutic Drugs for COVID-19.
    Asim MA
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):150-151. PubMed ID: 34271825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Ferneini EM
    J Oral Maxillofac Surg; 2021 Aug; 79(8):1801-1802. PubMed ID: 34334170
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone-Specific Drugs and Osteonecrosis of Sites Other Than the Jaw: A Nationwide Cohort Study.
    Nordström P; Bergman J; Ballin M; Björk S; Nordström A
    J Bone Miner Res; 2020 Sep; 35(9):1703-1710. PubMed ID: 32379370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaws.
    Toole J
    Rheumatology (Oxford); 2015 Oct; 54(10):1755-6. PubMed ID: 25877909
    [No Abstract]   [Full Text] [Related]  

  • 10. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 11. [The risk of bisphosphonate-related osteonecrosis of the jaw].
    Polymenidi I; Trombetti A; Carballo S
    Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced osteonecrosis of the jaw.
    Hamadeh IS; Ngwa BA; Gong Y
    Cancer Treat Rev; 2015 May; 41(5):455-64. PubMed ID: 25913713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maxillar osteonecrosis related to denosumab. Evaluation of nine cases.
    Sánchez López JD; Cariati P; Pérez de Perceval Tara M
    Med Clin (Barc); 2020 Aug; 155(4):180-181. PubMed ID: 31427154
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
    Goodwin JS; Zhou J; Kuo YF; Baillargeon J
    Mayo Clin Proc; 2017 Jan; 92(1):106-113. PubMed ID: 27876314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
    Sacco R; Ball R; Barry E; Akintola O
    Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis and spontaneous exfoliation of dental implants associated with oral bisphosphonate therapy: a case report.
    Rawal SY; Hilal G
    Aust Dent J; 2020 Mar; 65(1):100-103. PubMed ID: 31769879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
    Chang JI; Hazboun RC; Chang TI
    J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M; Antić S; Jelovac DB; Zarev AI; Petrović MB; Golubović M; Antunović M
    Vojnosanit Pregl; 2014 Aug; 71(8):772-6. PubMed ID: 25181838
    [No Abstract]   [Full Text] [Related]  

  • 20. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.